Hematology Drugs Market was valued at USD 85606.01 million in 2021 and is expected to reach USD 165631.48 million by 2029, registering a CAGR of 8.60% during the forecast period of 2022-2029. “Hospitals” accounts for the most prominent end user segment in the respective market owing to the rise in the number of blood disorder cases. The market report curated by DBMR research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.